SAN DIEGO, Oct. 6, 2017 /PRNewswire/ — Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Omega Protein Corporation (NYSE: OME) (“Omega Protein”) breached their fiduciary duties in connection with the proposed sale of the Company to Cooke Inc. Omega Protein develops, produces, and delivers products to enhance the nutritional integrity of foods, dietary supplements, and animal feeds worldwide.

On October 6, 2017, Omega Protein announced that it had signed a definitive merger agreement with Cooke. Terms of the deal call for shareholders to receive $22 per share for each share of Omega Protein stock they own.

The investigation concerns whether the Omega Protein board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Omega Protein shares of common stock. Nationally recognized Johnson Fistel is investigating whether the proposed deal price represents adequate consideration, especially given one Wall Street analyst has a $26.00 price target on the stock. The 52-week high for Omega Protein is $26.99.

If you are a shareholder of Omega Protein and believe the proposed buyout price is too low or you’re interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker at  619-814-4471. If emailing, please include a phone number.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
[email protected]